Murdoch-based Orthocell's push to expand the reach of its nerve repair product Remplir has continued, following news it has received regulatory approval in Hong Kong.
Vertex Minerals chair Roger Jackson says he is confident the explorer is on the cusp of significant cash generation, as it moves toward production at its Hill End gold project in NSW.
OPINION: Donald Trump's ‘Liberation Day' tariffs, and the almost-daily announcements of new, reduced or deferred tariffs, have conspired to create massive uncertainties across the world.
Perth-based Dalaroo Metals has confirmed the appointment of Chris Connell as its new chief executive, as the company aims to further enhance its portfolio moving forward.
The economic superpowers seem one step closer to reducing tensions as the US touts a trade deal and Chinese officials say they've reached an “important consensus” in Geneva.
Mixed metals miner South32 has announced a significant senior management transition, with chief executive and managing director Graham Kerr to leave the company next year.
US stocks ended the week on a quiet note after oscillating between slight gains and declines, as investors gauged president Donald Trump's comments on Chinese tariffs ahead of weekend trade talks between the two countries.
Transport and logistics company Centurion has booked a five-year deal with Australia Post, over freight delivery across three Western Australian regions.
Orthocell boss Paul Anderson said the Murdoch-based biotech medical company is “well ahead” of its original targets in relation to US sales of its nerve repair product, Remplir.
Ascent Investment and Coaching director Michael Dunjey appeared before a Perth court today, facing 33 criminal charges relating to an allegedly fraudulent scheme.
Perth consulting firm Ralph Beattie Bosworth has been awarded a contract to provide cost planning services for the proposed Women and Babies Hospital at Murdoch.